Site Members can sign up for company wide alerts
Lawsuit Overview
FEbruary 11, 2025 - An investor in shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) filed a lawsuit in the U.S. District Court for the District of Massachusetts over alleged violations of Federal Securities Laws by Intellia Therapeutics, Inc. in connection with certain allegedly false and misleading statements made between July 30, 2024 to January 8, 2025. Cambridge, MA based In...
You must register (for free) or login to view the entire case.